Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leah Rider

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Endocrinology (Baltimore, Md.)|May 14, 2011
Adapter protein SH2B1beta binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motilityLeah Rider, Maria Diakonova
Elife|October 28, 2015
SPOP the mutationLeah Rider, Scott D Cramer
Molecular Endocrinology (Baltimore, Md.)|June 8, 2013
PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IVLeah Rider, Peter Oladimeji, Maria Diakonova
Molecular Endocrinology (Baltimore, Md.)|July 2, 2011
PAK1-Nck regulates cyclin D1 promoter activity in response to prolactinJing Tao, Peter Oladimeji, Leah Rider, et al.
The Journal of Biological Chemistry|August 30, 2007
JAK2 tyrosine kinase phosphorylates PAK1 and regulates PAK1 activity and functionsLeah Rider, Alla Shatrova, Edward P Feener, et al.
Molecular Endocrinology (Baltimore, Md.)|April 4, 2009
Adapter protein SH2B1beta cross-links actin filaments and regulates actin cytoskeletonLeah Rider, Jing Tao, Stacy Snyder, et al.
Molecular Endocrinology (Baltimore, Md.)|January 24, 2013
Tyrosyl phosphorylated PAK1 regulates breast cancer cell motility in response to prolactin through filamin AAlan Hammer, Leah Rider, Peter Oladimeji, et al.
Molecular Cancer Therapeutics|August 15, 2014
Lipid catabolism via CPT1 as a therapeutic target for prostate cancerIsabel R Schlaepfer, Leah Rider, Lindsey Ulkus Rodrigues, et al.
Cancer Research|March 15, 2015
Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancerLindsey Ulkus Rodrigues, Leah Rider, Cera Nieto, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Endocrinology (Baltimore, Md.)|May 14, 2011
Adapter protein SH2B1beta binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motilityLeah Rider, Maria Diakonova
Elife|October 28, 2015
SPOP the mutationLeah Rider, Scott D Cramer
Molecular Endocrinology (Baltimore, Md.)|June 8, 2013
PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IVLeah Rider, Peter Oladimeji, Maria Diakonova
Molecular Endocrinology (Baltimore, Md.)|July 2, 2011
PAK1-Nck regulates cyclin D1 promoter activity in response to prolactinJing Tao, Peter Oladimeji, Leah Rider, et al.
The Journal of Biological Chemistry|August 30, 2007
JAK2 tyrosine kinase phosphorylates PAK1 and regulates PAK1 activity and functionsLeah Rider, Alla Shatrova, Edward P Feener, et al.
Molecular Endocrinology (Baltimore, Md.)|April 4, 2009
Adapter protein SH2B1beta cross-links actin filaments and regulates actin cytoskeletonLeah Rider, Jing Tao, Stacy Snyder, et al.
Molecular Endocrinology (Baltimore, Md.)|January 24, 2013
Tyrosyl phosphorylated PAK1 regulates breast cancer cell motility in response to prolactin through filamin AAlan Hammer, Leah Rider, Peter Oladimeji, et al.
Molecular Cancer Therapeutics|August 15, 2014
Lipid catabolism via CPT1 as a therapeutic target for prostate cancerIsabel R Schlaepfer, Leah Rider, Lindsey Ulkus Rodrigues, et al.
Cancer Research|March 15, 2015
Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancerLindsey Ulkus Rodrigues, Leah Rider, Cera Nieto, et al.
Pageof 1